SG11201604705UA - Method for manufacturing ciliary marginal zone-like structure - Google Patents
Method for manufacturing ciliary marginal zone-like structureInfo
- Publication number
- SG11201604705UA SG11201604705UA SG11201604705UA SG11201604705UA SG11201604705UA SG 11201604705U A SG11201604705U A SG 11201604705UA SG 11201604705U A SG11201604705U A SG 11201604705UA SG 11201604705U A SG11201604705U A SG 11201604705UA SG 11201604705U A SG11201604705U A SG 11201604705UA
- Authority
- SG
- Singapore
- Prior art keywords
- manufacturing
- marginal zone
- ciliary marginal
- ciliary
- zone
- Prior art date
Links
- 230000001886 ciliary effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/73—Hydrolases (EC 3.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013255836 | 2013-12-11 | ||
PCT/JP2014/077602 WO2015087614A1 (ja) | 2013-12-11 | 2014-10-16 | 毛様体周縁部様構造体の製造法 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201604705UA true SG11201604705UA (en) | 2016-07-28 |
Family
ID=53370932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201604705UA SG11201604705UA (en) | 2013-12-11 | 2014-10-16 | Method for manufacturing ciliary marginal zone-like structure |
Country Status (12)
Country | Link |
---|---|
US (2) | US10233423B2 (zh) |
EP (2) | EP3081637B1 (zh) |
JP (3) | JP6495830B2 (zh) |
KR (1) | KR102318706B1 (zh) |
CN (1) | CN105960454B (zh) |
AU (1) | AU2014362722B2 (zh) |
CA (1) | CA2933258C (zh) |
DK (1) | DK3081637T3 (zh) |
ES (1) | ES2741309T3 (zh) |
MY (1) | MY184796A (zh) |
SG (1) | SG11201604705UA (zh) |
WO (1) | WO2015087614A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11241460B2 (en) | 2013-03-15 | 2022-02-08 | Astellas Institute For Regenerative Medicine | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
US10233423B2 (en) * | 2013-12-11 | 2019-03-19 | Sumitomo Chemical Company, Limited | Method for manufacturing ciliary marginal zone-like structure |
JP6571533B2 (ja) | 2014-01-17 | 2019-09-04 | 住友化学株式会社 | 毛様体周縁部幹細胞の製造方法 |
JP6682446B2 (ja) | 2014-10-24 | 2020-04-15 | 大日本住友製薬株式会社 | 網膜組織の製造方法 |
IL251855B2 (en) | 2014-10-24 | 2023-09-01 | Sumitomo Pharma Co Ltd | A method for producing nerve tissue |
CA3021828A1 (en) | 2016-04-22 | 2017-10-26 | Sumitomo Dainippon Pharma Co., Ltd. | Method for producing retinal tissue |
CA3070215A1 (en) | 2017-07-20 | 2019-01-24 | Riken | Method for maturation of retinal tissue containing continuous epithelium |
EP3683306A4 (en) | 2017-09-14 | 2021-06-09 | Riken | RETINAL TISSUE PRODUCTION PROCESS |
CA3075883A1 (en) | 2017-09-14 | 2019-03-21 | Riken | Method for amplifying cone photoreceptors or rod photoreceptors using dorsalization signal transmitter or ventralization signal transmitter |
JP7558501B2 (ja) * | 2019-03-13 | 2024-10-01 | 住友ファーマ株式会社 | 移植用神経網膜の品質を評価する方法及び移植用神経網膜シート |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE903130A1 (en) | 1989-09-15 | 1991-03-27 | Regeneron Pharma | Ciliary neurotrophic factor |
US6045791A (en) * | 1992-03-06 | 2000-04-04 | Photogenesis, Inc. | Retinal pigment epithelium transplantation |
AU5734998A (en) | 1997-01-10 | 1998-08-03 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
US6007578A (en) | 1997-10-08 | 1999-12-28 | Ras Holding Corp | Scleral prosthesis for treatment of presbyopia and other eye disorders |
CN1720055A (zh) | 2002-10-04 | 2006-01-11 | 组织技术公司 | 视网膜上皮细胞在羊膜上的培养和移植 |
WO2006079036A2 (en) | 2005-01-21 | 2006-07-27 | Northwestern University | Methods and compositions for encapsulation of cells |
US8927276B2 (en) | 2010-02-17 | 2015-01-06 | Cellin Technologies Oue | Ex vivo progenitor and stem cell expansion and differentiation for use in the treatment of disease of the nervous system |
EP2826860B1 (en) | 2010-04-23 | 2018-08-22 | University of Massachusetts | CNS targeting AAV vectors and methods of use thereof |
SG187845A1 (en) | 2010-08-16 | 2013-03-28 | Brainstem Biotech Ltd | Methods of generating oligodendrocytes and cell populations comprising same |
US10973854B2 (en) | 2011-11-25 | 2021-04-13 | Sumitomo Chemical Company, Limited | Methods for producing retinal tissue and retina-related cell |
JP5985209B2 (ja) | 2011-11-25 | 2016-09-06 | 住友化学株式会社 | 眼杯様構造体の製造方法 |
JP6067232B2 (ja) | 2011-11-25 | 2017-01-25 | 住友化学株式会社 | 網膜層特異的神経細胞を製造する方法 |
JP5985207B2 (ja) | 2011-11-25 | 2016-09-06 | 住友化学株式会社 | 網膜色素上皮細胞の製造方法 |
JP5985208B2 (ja) | 2011-11-25 | 2016-09-06 | 住友化学株式会社 | 網膜組織の製造方法 |
JP2013201943A (ja) | 2012-03-28 | 2013-10-07 | Sumitomo Chemical Co Ltd | 成熟肝細胞の製造方法 |
JP6089430B2 (ja) | 2012-03-30 | 2017-03-08 | セイコーエプソン株式会社 | 軟磁性粉末、圧粉磁心および磁性素子 |
JP6393614B2 (ja) | 2012-06-08 | 2018-09-19 | 住友化学株式会社 | 毛様体周縁部様構造体の製造方法 |
US10233423B2 (en) * | 2013-12-11 | 2019-03-19 | Sumitomo Chemical Company, Limited | Method for manufacturing ciliary marginal zone-like structure |
-
2014
- 2014-10-16 US US15/103,162 patent/US10233423B2/en active Active
- 2014-10-16 MY MYPI2016702127A patent/MY184796A/en unknown
- 2014-10-16 AU AU2014362722A patent/AU2014362722B2/en active Active
- 2014-10-16 EP EP14869571.1A patent/EP3081637B1/en active Active
- 2014-10-16 SG SG11201604705UA patent/SG11201604705UA/en unknown
- 2014-10-16 CA CA2933258A patent/CA2933258C/en active Active
- 2014-10-16 ES ES14869571T patent/ES2741309T3/es active Active
- 2014-10-16 EP EP19165595.0A patent/EP3524671A1/en active Pending
- 2014-10-16 WO PCT/JP2014/077602 patent/WO2015087614A1/ja active Application Filing
- 2014-10-16 KR KR1020167018419A patent/KR102318706B1/ko active IP Right Grant
- 2014-10-16 DK DK14869571.1T patent/DK3081637T3/da active
- 2014-10-16 JP JP2015552354A patent/JP6495830B2/ja active Active
- 2014-10-16 CN CN201480074995.4A patent/CN105960454B/zh active Active
-
2019
- 2019-02-05 US US16/267,948 patent/US11111476B2/en active Active
- 2019-03-07 JP JP2019042043A patent/JP6991517B2/ja active Active
-
2021
- 2021-09-14 JP JP2021149779A patent/JP2021192634A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20190169570A1 (en) | 2019-06-06 |
EP3081637A1 (en) | 2016-10-19 |
JPWO2015087614A1 (ja) | 2017-03-16 |
CN105960454A (zh) | 2016-09-21 |
KR20160097303A (ko) | 2016-08-17 |
JP6991517B2 (ja) | 2022-02-15 |
AU2014362722B2 (en) | 2021-06-10 |
CN105960454B (zh) | 2020-10-30 |
EP3081637A4 (en) | 2017-07-05 |
WO2015087614A1 (ja) | 2015-06-18 |
EP3524671A1 (en) | 2019-08-14 |
EP3081637B1 (en) | 2019-05-08 |
AU2014362722A1 (en) | 2016-07-28 |
KR102318706B1 (ko) | 2021-10-28 |
JP2021192634A (ja) | 2021-12-23 |
US20160376554A1 (en) | 2016-12-29 |
CA2933258C (en) | 2023-05-23 |
MY184796A (en) | 2021-04-22 |
JP6495830B2 (ja) | 2019-04-03 |
US10233423B2 (en) | 2019-03-19 |
CA2933258A1 (en) | 2015-06-18 |
DK3081637T3 (da) | 2019-08-12 |
US11111476B2 (en) | 2021-09-07 |
ES2741309T3 (es) | 2020-02-10 |
JP2019115351A (ja) | 2019-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2520596B (en) | Manufacturing method | |
HK1223993A1 (zh) | 製作物體的方法 | |
EP2978018A4 (en) | METHOD FOR PRODUCING A CURRENT MODULE SUBSTRATE | |
EP3020807A4 (en) | Method for manufacturing useful substance | |
EP2949457A4 (en) | SHOES AND METHOD FOR THE MANUFACTURE THEREOF | |
IL243207B (en) | Process for manufacturing 4 -propargylated amino-benzoxazinones | |
EP3089201A4 (en) | Method for manufacturing enhanced component | |
SG11201604705UA (en) | Method for manufacturing ciliary marginal zone-like structure | |
EP2966679A4 (en) | METHOD FOR PRODUCING A CURRENT MODULE SUBSTRATE | |
EP2963156A4 (en) | METHOD FOR MANUFACTURING REDUCED GLUTATHION | |
EP2860245A4 (en) | PROCESS FOR PRODUCING A CILIA MARGINAL AREA TYPE STRUCTURE | |
HK1216098A1 (zh) | 沃替西汀生產方法 | |
EP2960218A4 (en) | METHOD OF MAKING A BASIC MATERIAL | |
SG11201600510VA (en) | Method for manufacturing grease | |
SG11201601359VA (en) | Method for producing mirror-polished wafer | |
GB201306544D0 (en) | Method for releasing overlaps | |
EP2966111A4 (en) | PROCESS FOR PRODUCING NYLON 6 | |
HUE037846T2 (hu) | Eljárás izocianátok elõállítására | |
GB201301034D0 (en) | Lace manufacturing method | |
EP3040437A4 (en) | MECHANICAL STRUCTURAL COMPONENT AND METHOD FOR MANUFACTURING THE SAME | |
PL2956246T3 (pl) | Sposób wytwarzania elementów kompozytowych | |
EP3029145A4 (en) | PROCESS FOR PRODUCTION OF METHACRYLYL-CoA | |
EP2949643A4 (en) | PROCESS FOR THE PRODUCTION OF MEMANTINE | |
EP2891645A4 (en) | MANUFACTURING METHOD FOR A CONNECTION | |
HK1209598A1 (zh) | 方便面的製造方法 |